ClinicalTrials.Veeva

Menu

Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice

N

Natural Origins

Status and phase

Completed
Phase 2

Conditions

Muscle Soreness
Delayed-onset Muscle Soreness

Treatments

Dietary Supplement: Polyherbal supplement: ReWin(d) vs Placebo

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03961022
Nat.Origins-ReWin(d)-2019

Details and patient eligibility

About

The study will assess the recovery and performance of young athletes suffering from muscle damage induced by physical exercise. Model by comparing the safety and efficacy of ReWin(d) supplemention during 4 weeks to placebo over 72 hours post exercice.

Full description

Double-blind, randomized, placebo controlled, parallel group, pilot safety and efficacy study.

40 healthy young male athetes were randomly assigned to the ReWin(d) or Placebo group. After 4 weeks supplementation (either 2 g daily of ReWin(d) capsules or placebo capsules). the participants were subjected to a 1 hour plyometric exercise session to induce DOMS. At 0 hours, 24 hours, 48 hours and 72 hours post exercise, the volunteers have been assessed to determine: (i) pain perception, (ii) fatigue rate, (iii) sport performance (effectiveness of a jump) and (iv) muscle damage and inflammation by I-R thermography and biomarkers

Enrollment

40 patients

Sex

Male

Ages

20 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • > 18 years old
  • Young athletes
  • Training at least 3 times per week
  • Agree not to initiate any new exercise or diet programs during the entire study period
  • Agree not to change their current diet or exercise program during the entire study period
  • Agree not to stretch, utilize ice massage, take anti-inflammatory medications (eg, aspirin, ibuprofen), or use any other treatment for the duration of the trial.

Exclusion criteria

  • Previous history of upper extremity injury or knee joint pain
  • Use of anti-inflammatory medications or pain medications 1 week before the screening visit and during the study
  • Daily use of dietary supplements and herbal supplements beginning at the screening visit and during the study
  • Antibiotic use in past 3 months
  • Chronic disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups, including a placebo group

ReWin(d)
Active Comparator group
Description:
Subjects have to take ReWin(d) capsules (3 times a day, total 2 g/day) during breakfast, lunch and diner, during 4 weeks + 3 days after acute exercice
Treatment:
Dietary Supplement: Polyherbal supplement: ReWin(d) vs Placebo
placebo
Placebo Comparator group
Description:
Subjects have to take Placebo capsules (3 times a day, total 2 g/day) during breakfast, lunch and diner, during 4 weeks + 3 days after acute exercice
Treatment:
Dietary Supplement: Polyherbal supplement: ReWin(d) vs Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems